Home NuPathe shares soar on news of competing bid
 

Keywords :   


NuPathe shares soar on news of competing bid

2014-01-09 02:36:00| Biotech - Topix.net

NuPathe said in a Securities and Exchange Commission filing that Israel's Teva Pharmaceutical Industries Ltd. wants to buy the company for $3.65 in cash for each NuPathe share, plus up to $3.15 per share in payments if NuPathe's migraine treatment patch Zecuity reaches certain sales milestones.

Tags: news bid shares competing

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
29.06Atlantic Tropical Weather Outlook
29.06Eastern North Pacific Tropical Weather Outlook
28.06What we learned from IT expert at Post Office inquiry
28.06M&S to launch clothing repairs service
28.06Tropical Depression Two Graphics
28.06Tropical Depression Two Public Advisory Number 1
28.06Summary for Tropical Depression Two (AT2/AL022024)
28.06Tropical Depression Two Forecast Advisory Number 1
More »